Faculty of Science
Faculty of Pharmacy & Pharmaceutical Sciences – Pharmaceutical Sciences.
Value of virology-immunology grants/funding held by U of A researchers:
Canadian Institutes of Health Research – $10 million
Canadian Foundation for Innovation – $39.4 million
GlaxoSmithKline – $20 million
(Salary support and operating grants prior to the creation of the Li Ka Shing Institute of Virology. As an indication of the level of virus research activity, these dollar amounts show the University of Alberta stands out as the clear leader among Canadian universities.)
Viruses currently being studied: Herpesviruses, flaviviruses (West Nile, dengue, yellow fever), retroviruses (HIV), poxviruses, adenovirus (respiratory), influenza A, hepatitis B, hepatitis C, rubella.
Main research areas:
How viruses cause disease/function.
Development of vaccines and improvement of existing vaccines to better prevent viruses.
Development of new, innovative drugs to treat viral infections.
Development of more sensitive and accurate methods for diagnosing virus infections.
Key research groups:
Li Ka Shing Institute of Virology
Alberta Transplant Applied Genomics Centre
Centre of Excellence for Gastrointestinal Inflammation and Immunity Research
Katz Group Centre for Pharmacy & Health Research
Li Ka Shing Centre for Health Research Innovation
Glaxo Level 3 biocontainment facility
University of Alberta Hospital
(These buildings house facilities used in virology/immunology research: Laboratories; state-of-the-art microscope/imaging facilities; facilities for molecular, genomic and bioinformatics analysis.)